CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
688091 Shanghai Yizhong Pharmaceutical
- 43.47
- +0.97+2.28%
Market Closed Apr 30 15:00 CST
8.99BMarket Cap-1114.62P/E (TTM)
44.09High42.01Low21.43KlotVolume42.64Open42.50Pre Close92.96MTurnover1.04%Turnover Ratio1278.53P/E (Static)206.70MShares53.1852wk High6.32P/B8.99BFloat Cap20.2752wk Low51.00Limit Up206.70MShs Float101.81Historical High34.00Limit Down4.89%Amplitude19.31Historical Low0.24Dividend TTM43.39Avg Price7.34KlotAsk0.55%Div YieldTTM100Lot Size12.99KlotBid
Shanghai Yizhong Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 3.39%71.03M | -51.83%173.53M | -39.25%169.61M | -39.17%121.92M | -25.65%68.7M | 52.68%360.25M | 67.87%279.2M | 178.88%200.43M | 169.06%92.4M | 5,686.75%235.96M |
| Operating revenue | 3.39%71.03M | -51.83%173.53M | -39.25%169.61M | -39.17%121.92M | -25.65%68.7M | 52.68%360.25M | 67.87%279.2M | 178.88%200.43M | 169.06%92.4M | 5,686.75%235.96M |
| Total operating cost | 44.84%53.59M | 5.32%177.25M | 10.44%136.61M | 10.57%84.81M | 38.38%37M | 58.58%168.3M | 72.00%123.69M | 326.22%76.7M | 180.22%26.74M | 323.59%106.13M |
| Operating cost | 254.22%13.22M | -43.47%13.33M | -51.39%9.19M | -52.46%6.6M | -47.45%3.73M | 38.99%23.59M | 60.37%18.91M | 150.76%13.88M | 206.46%7.1M | 5,636.79%16.97M |
| Operating tax surcharges | -33.95%214.26K | -37.25%1.01M | -34.57%814.72K | -35.04%579.26K | -22.76%324.38K | 78.03%1.61M | 129.07%1.25M | 333.09%891.67K | 6,969.03%419.94K | 3,458.89%904.66K |
| Operating expense | 10.27%28.21M | 8.28%115.46M | 6.36%83.79M | 10.21%53.49M | 73.01%25.58M | 19.77%106.63M | 32.45%78.78M | 325.22%48.53M | 209.77%14.79M | 3,740.98%89.03M |
| Administration expense | -25.80%6.21M | -32.62%27.59M | 10.09%31.13M | 6.56%18.95M | -2.02%8.38M | 325.92%40.94M | 327.64%28.28M | 316.39%17.79M | 284.55%8.55M | -35.81%9.61M |
| Financial expense | 46.31%-3.55M | 35.58%-17.35M | 32.45%-13.66M | 24.16%-10.14M | 1.64%-6.61M | -46.99%-26.92M | -79.64%-20.23M | -124.06%-13.37M | -444.49%-6.72M | -215.85%-18.32M |
| -Interest expense (Financial expense) | ---- | 159.62%700.86K | 225.62%699.68K | 396.41%592.94K | 299.37%266.54K | 3,248.37%269.96K | -56.28%214.88K | -14.40%119.44K | 171.09%66.74K | -101.46%-8.57K |
| -Interest Income (Financial expense) | 48.38%-3.55M | 33.42%-18.14M | 29.46%-14.45M | 20.07%-10.82M | -1.32%-6.88M | -48.72%-27.25M | -74.24%-20.49M | -121.51%-13.54M | -493.67%-6.79M | -186.11%-18.32M |
| Research and development | 65.78%9.28M | 65.71%37.2M | 51.70%25.34M | 70.62%15.33M | 114.99%5.6M | 183.26%22.45M | 251.84%16.71M | 254.02%8.99M | 78.71%2.6M | -40.14%7.93M |
| Credit Impairment Loss | -260.02%-894.38K | 193.15%5.06M | 117.60%881.48K | 105.85%239.1K | 131.56%558.91K | -167.23%-5.43M | -213.97%-5.01M | -174.77%-4.09M | -148.26%-1.77M | -840.77%-2.03M |
| Asset Impairment Loss | ---- | 88.46%-4.24K | ---4.24K | ---- | ---- | ---36.75K | ---- | ---- | ---- | ---- |
| Other net revenue | ||||||||||
| Fair value change income | -97.18%9.42K | ---- | -99.08%8.05K | -58.36%708.26K | -61.72%333.83K | -53.35%418.49K | -23.83%880.27K | 104.35%1.7M | 327.48%872.05K | -72.39%897.09K |
| Invest income | -125.59%-380.24K | -2.81%6.9M | 48.82%7.37M | 51.55%3.52M | 34.82%1.49M | -40.81%7.1M | -48.06%4.95M | -67.29%2.32M | -79.29%1.1M | 447.22%12M |
| Other revenue | -12.64%315.93K | -9.75%1.3M | 63.24%1.15M | 97.02%967.96K | 29.24%361.65K | -86.74%1.45M | -39.13%704.79K | 13.89%491.31K | 27.25%279.83K | 68.43%10.9M |
| Operating profit | -52.11%16.5M | -95.12%9.54M | -73.00%42.41M | -65.73%42.55M | -47.92%34.45M | 28.94%195.45M | 50.04%157.04M | 104.38%124.15M | 121.73%66.15M | 1,733.23%151.59M |
| Add:Non operating Income | ---- | -54.97%1.08K | -54.97%1.08K | -55.00%1.08K | ---- | 300.00%2.4K | 300.00%2.4K | --2.4K | --2.4K | --600 |
| Less:Non operating expense | 3.23%1.01M | -44.78%4.72M | -25.30%4.31M | 16.47%3.61M | -46.53%976.5K | 322.23%8.56M | 306.66%5.77M | 329.06%3.1M | --1.83M | --2.03M |
| Total profit | -53.72%15.49M | -97.42%4.82M | -74.81%38.1M | -67.84%38.94M | -47.97%33.47M | 24.97%186.9M | 46.52%151.28M | 101.67%121.06M | 115.62%64.32M | 1,711.40%149.56M |
| Less:Income tax cost | -69.62%1.3M | -108.51%-2.16M | -83.39%3.43M | -73.87%4.43M | -53.85%4.29M | 277.93%25.35M | 2,351.12%20.65M | 1,877.37%16.95M | 1,118.76%9.3M | 226.91%6.71M |
| Net profit | -51.38%14.19M | -95.68%6.98M | -73.46%34.67M | -66.85%34.51M | -46.97%29.18M | 13.09%161.55M | 25.40%130.62M | 70.73%104.11M | 78.98%55.03M | 3,674.01%142.85M |
| Net profit from continuing operation | -51.38%14.19M | -95.68%6.98M | -73.46%34.67M | -66.85%34.51M | -46.97%29.18M | 13.09%161.55M | 25.40%130.62M | 70.73%104.11M | 78.98%55.03M | 3,674.01%142.85M |
| Net profit of parent company owners | -51.38%14.19M | -95.68%6.98M | -73.46%34.67M | -66.85%34.51M | -46.97%29.18M | 13.09%161.55M | 25.40%130.62M | 70.73%104.11M | 78.98%55.03M | 3,674.01%142.85M |
| Earning per share | ||||||||||
| Basic earning per share | -61.11%0.07 | -97.06%0.03 | -79.52%0.17 | -74.24%0.17 | -52.63%0.18 | 3.03%1.02 | -15.31%0.83 | 13.79%0.66 | 31.03%0.38 | 2,080.00%0.99 |
| Diluted earning per share | -61.11%0.07 | -97.06%0.03 | -79.52%0.17 | -74.24%0.17 | -52.63%0.18 | 3.03%1.02 | -15.31%0.83 | 13.79%0.66 | 31.03%0.38 | 2,080.00%0.99 |
| Other composite income | ||||||||||
| Total composite income | -51.38%14.19M | -95.68%6.98M | -73.46%34.67M | -66.85%34.51M | -46.97%29.18M | 13.09%161.55M | 25.40%130.62M | 70.73%104.11M | 78.98%55.03M | 3,674.01%142.85M |
| Total composite income of parent company owners | -51.38%14.19M | -95.68%6.98M | -73.46%34.67M | -66.85%34.51M | -46.97%29.18M | 13.09%161.55M | 25.40%130.62M | 70.73%104.11M | 78.98%55.03M | 3,674.01%142.85M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.